Analyst Ratings for Sucampo Pharmaceuticals Inc. Cl A (SCMP)Updated: 2017-07-28
An average rating of Buy has been given to Sucampo Pharmaceuticals Inc. Cl A (NASDAQ:SCMP) by analysts covering the stock. SCMP had previously received a consensus rating of Buy a month ago.
4 analysts declared SCMP a buy, 0 issued an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Many analysts weighed in on price targets for SCMP. The most optimistic analyst gave a price target of 29.5, implying potential capital gains of 171.89 percent. The most pessimistic analyst gave a price target of 11, which equates to a potential downside of 1.38 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -8.07 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -12.21 percent in FY estimates.
People are often interested in whether analysts were united in the direction of their revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.
Analysts estimate earnings of SCMP to grow at a rate of 66.42 percent. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, as that can indicate whether the high price level of a stock is warranted by high growth. PEG ratios below 1 are often considered desirable, but many choose to perform ratio comparisons with other companies in the industry. SCMP has a PEG ratio of 0.27.
SCMP has traded between a high of 17.55 and a low of 9.30 over the past year. Today's price is 16.67 percent above the 52-week low, and below the high by 38.18 percent. SCMP has a price/earnings ratio of 17.79. Investors typically compare the P/E ratio to a company's peers in the industry. The SCMP value stock report compares SCMP to some of its peers using value stock charts. The stock has a market capitalization of $0.50182 billion. SCMP is estimated to release their earnings results for the quarter on 0000-00-00, days from today.